Differentiating mega cisterna magna from cisterna magna arachnoid cysts: The diagnostic utility of quantitative diffusion‐weighted imaging parameters

Q. Li, Zhe Feng, Haichao Cheng, Xin Cao, Yaping Ge, Hao Shi, Junying WangJournal of Applied Clinical Medical Physics 2025 · DOI

TL;DR

This study investigates the diagnostic utility of diffusion-weighted imaging (DWI) parameters, specifically the apparent diffusion coefficient (ADC) and exponential apparent diffusion coefficient (eADC), for differentiating mega cisterna magna (MCM) from cisterna magna arachnoid cysts (CMAC). The findings suggest that these quantitative DWI metrics can effectively distinguish between these two conditions, offering a valuable tool for clinical diagnosis.

What Problem Does This Paper Address?

Mega cisterna magna (MCM) and cisterna magna arachnoid cysts (CMAC) are both conditions involving the cisterna magna, a space at the base of the cerebellum. While often asymptomatic, symptomatic cases can require surgical intervention. However, differentiating between MCM and CMAC can be challenging with conventional imaging techniques. MCM is a congenital enlargement of the cisterna magna, while CMAC is a cystic lesion within that space. Accurate differentiation is crucial for guiding clinical management, particularly in determining the necessity of surgical intervention. This paper aims to explore whether quantitative diffusion-weighted imaging (DWI) parameters can provide a more objective and reliable method for this differentiation.

Methods

The study employed a retrospective analysis of MRI data from patients diagnosed with MCM, CMAC, and a control group of temporal arachnoid cysts (TAC). The core of the methodology lies in the quantitative analysis of DWI-derived parameters:

  • Apparent Diffusion Coefficient (ADC): This parameter quantifies the overall magnitude of water molecule diffusion within tissues. Lower ADC values indicate restricted diffusion.
  • Exponential Apparent Diffusion Coefficient (eADC): This parameter is derived from the signal intensity ratio between high- and low-b-value DWI acquisitions. It's designed to mitigate the T2 shine-through effect, which can confound ADC measurements, by normalizing signal differences independent of ADC.

Two experienced neuroradiologists independently reviewed the imaging data. Regions of interest (ROIs) were placed in the lesion core (for MCM/CMAC) or cystic cavity (for TAC), as well as in the lateral and fourth ventricles to measure CSF diffusion metrics. Statistical analysis, including independent samples t-tests and Mann-Whitney U tests, was used to compare ADC and eADC values between the groups.

Datasets

The study involved a prospective enrollment of 121 patients between 2019 and 2024, categorized into three groups:

  • Group A (MCM): 40 patients.
  • Group B (CMAC): 45 patients.
  • Group C (TAC control): 36 patients.

Cases with ambiguous imaging features that prevented definitive differentiation between MCM and CMAC were excluded to ensure diagnostic homogeneity.

Key Insights and Ideas

  • DWI as a Quantitative Differentiator: The study highlights that DWI, a non-invasive imaging technique, can provide quantitative metrics (ADC and eADC) that go beyond visual interpretation to differentiate between MCM and CMAC.
  • Microstructural Differences: The observed differences in ADC and eADC values likely reflect underlying microstructural variations in fluid dynamics between MCM and CMAC. MCM, with its open CSF communication, may exhibit different diffusion characteristics compared to the more encapsulated nature of CMAC.
  • eADC's Role in Mitigating T2 Shine-Through: The eADC parameter appears to be particularly useful in overcoming the limitations of conventional DWI, such as the T2 shine-through effect, offering a more refined measure of diffusion restriction.
  • TAC as a Valid Control: The study validates the use of temporal arachnoid cysts (TAC) as a suitable control group for studies involving arachnoid cysts, showing no significant ADC/eADC differences compared to CMAC.

Key Results

  • Significant Differences in eADC: The eADC values for MCM, CMAC, and TAC were (3.75 ± 0.27) × 10⁻², (4.53 ± 0.54)×10⁻², and (4.35 ± 0.30) ×10⁻² mm²/s, respectively. While there was no significant difference between CMAC and TAC, MCM showed a significant difference from both (p = 0.000).
  • Significant Differences in ADC: The ADC values for MCM, CMAC, and TAC were (3.30 ± 0.08) × 10⁻³, (3.11 ± 0.12) ×10⁻³, and (2.97 ± 0.71) × 10⁻³ mm²/s, respectively. Significant differences in ADC were observed between MCM and both CMAC and TAC (p = 0.000/0.003).
  • MCM vs. CMAC: MCM demonstrated significantly higher ADC values (p = 0.00) and lower eADC values (p = 0.00) compared to CMAC.
  • CSF vs. Lesion Diffusion: Both MCM and CMAC showed significantly lower ADC values compared to intraventricular CSF within the same group, suggesting restricted water diffusivity in these entities.

Limitations and Future Work

  • Absence of Histopathological Confirmation: A key limitation acknowledged by the authors is the lack of histopathological confirmation for MCM and CMAC, as these benign entities rarely require surgical intervention. However, they note that ambiguous cases were excluded, and all included cases were typical and evaluated by experienced radiologists.
  • Limited Literature on New Studies: The authors mention that much of the referenced literature is older, with a lack of citations for newer studies, suggesting a need for more contemporary research in this area.
  • Further Validation of eADC: While eADC showed promise, the authors note that it is less validated for clinical use in differentiating posterior fossa CSF collections compared to ADC, warranting further investigation.
  • Future Directions: The study's findings pave the way for further research into the quantitative assessment of retrocerebellar CSF collections, potentially leading to improved diagnostic accuracy and personalized treatment strategies.

Summary updated

Abstract

DWI-derived ADC and eADC parameters can effectively differentiate mega cisterna magna from cisterna magna arachnoid cysts.
BibTeX
@article{li2025differentiating,
  author = {Q. Li and Zhe Feng and Haichao Cheng and Xin Cao and Yaping Ge and Hao Shi and Junying Wang},
  title = {{Differentiating mega cisterna magna from cisterna magna arachnoid cysts: The diagnostic utility of quantitative diffusion‐weighted imaging parameters}},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2025},
  doi = {10.1002/acm2.70166},
}
Figure